SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-008391
Filing Date
2020-05-12
Accepted
2020-05-12 16:57:28
Documents
56
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 480069
2 ex31-1.htm EX-31.1 18942
3 ex31-2.htm EX-31.2 18698
4 ex32-1.htm EX-32.1 7565
5 ex32-2.htm EX-32.2 7452
  Complete submission text file 0001493152-20-008391.txt   2988990

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE prph-20200331.xml EX-101.INS 465121
7 XBRL SCHEMA FILE prph-20200331.xsd EX-101.SCH 50463
8 XBRL CALCULATION FILE prph-20200331_cal.xml EX-101.CAL 49683
9 XBRL DEFINITION FILE prph-20200331_def.xml EX-101.DEF 133201
10 XBRL LABEL FILE prph-20200331_lab.xml EX-101.LAB 301833
11 XBRL PRESENTATION FILE prph-20200331_pre.xml EX-101.PRE 203036
Mailing Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901
Business Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901 2153450919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21617 | Film No.: 20869830
SIC: 2834 Pharmaceutical Preparations